Overview

A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors

Status:
RECRUITING
Trial end date:
2026-08-20
Target enrollment:
Participant gender:
Summary
This study is a single-dose, open-label, 2-cycle crossover design, comparing the pharmacokinetic parameters and safety of Inhaled Fentanyl Aerosol and intravenous fentanyl injection.
Phase:
PHASE1
Details
Lead Sponsor:
Lee's Pharmaceutical Limited
Treatments:
Fentanyl